Fundraising Fox
ILC Therapeutics Ltd
Glasgow, GB · 2 known investors
Find your way into ILC Therapeutics Ltd
Sign up to see every warm intro you have to ILC Therapeutics Ltd
- Paths you didn't know you had: your email and LinkedIn already hold routes to the ILC Therapeutics Ltd team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.
Founders & leadership
OM
Owain MillingtonChief Executive OfficerOwain Millington is a scientist and biotechnology executive with a background as a Principal Investigator in immunology research in academia and over a decade of experience leading immunology-focused biotech companies at the CEO and VP level, taking drug development programs from early stage through IND-enabling studies.
Investors · 2
Eos Advisorylisted by Eos AdvisorySt Andrews
How we know: the VCSheet dataset · Not right? Tell us
Companies House · registry record
View on Companies House ↗Confirmation statement overdue
- Registered name
- ILC THERAPEUTICS LTD
- Company number
- SC426667
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 21 Jun 2012
- Registered office
- Suite 2, Ground Floor Orchard Brae House, 30 Queensferry Road, Edinburgh, EH4 2HS
- Nature of business (SIC)
- 72110 — Research and experimental development on biotechnology
- Previous names
- ALFACYTE LIMITED (2012–2019)
- Accounts
- last made up to 30 Jun 2025 · next due 31 Mar 2027
- Confirmation statement
- last made up to 13 Jul 2025 · next due 27 Jul 2026
Current officers · 7
- Mbm Secretarial Services Limited — corporate secretary, appointed 3 Feb 2023
- Peter James Jonathan Bains — director, appointed 12 May 2021
- Christopher David Brinsmead — director, appointed 1 Sept 2021
- Kevin Gawn Grainger — director, appointed 15 Jul 2015
- David Harrison — director, appointed 1 Sept 2021
- Robert Kopple — director, appointed 2 Sept 2021
- Owain Richard Millington — director, appointed 1 Jul 2024
Source: Companies House public register · retrieved 5 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
Frequently asked questions
- What does ILC Therapeutics Ltd do?
- ILC Therapeutics is a biotechnology company developing hybrid interferon therapeutics, including its Alfacyte product, based on an interferon platform. The company operates in the drug development and pharmaceutical industry.
- Who are ILC Therapeutics Ltd's investors?
- ILC Therapeutics Ltd's investors include Eos Advisory, Medical Incubator Japan K.K..
- Where is ILC Therapeutics Ltd headquartered?
- ILC Therapeutics Ltd is headquartered in Glasgow, GB.